Patents by Inventor Malin Bern

Malin Bern has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10781245
    Abstract: The present invention relates to albumin variants with an improved affinity for the neonatal Fc receptor (FcRn) and uses thereof, and in particular to the use of such albumin variants as carriers for immunogens. In some embodiments, the present invention relates to vaccines (e.g., vaccines for mucosal delivery) comprising albumin/immunogen fusion proteins.
    Type: Grant
    Filed: January 17, 2019
    Date of Patent: September 22, 2020
    Assignee: University of Oslo
    Inventors: Jan Terje Andersen, Inger Sandlie, Malin Bern
  • Publication number: 20190135895
    Abstract: The present invention relates to albumin variants with an improved affinity for the neonatal Fc receptor (FcRn) and uses thereof, and in particular to the use of such albumin variants as carriers for immunogens. In some embodiments, the present invention relates to vaccines (e.g., vaccines for mucosal delivery) comprising albumin/immunogen fusion proteins.
    Type: Application
    Filed: January 17, 2019
    Publication date: May 9, 2019
    Inventors: Jan Terje Andersen, Inger Sandlie, Malin Bern
  • Patent number: 10208102
    Abstract: The present invention relates to albumin variants with an improved affinity for the neonatal Fc receptor (FcRn) and uses thereof, and in particular to the use of such albumin variants as carriers for immunogens. In some embodiments, the present invention relates to vaccines (e.g., vaccines for mucosal delivery) comprising albumin/immunogen fusion proteins.
    Type: Grant
    Filed: October 31, 2014
    Date of Patent: February 19, 2019
    Assignee: UNIVERSITY OF OSLO
    Inventors: Jan Terje Andersen, Inger Sandlie, Malin Bern
  • Publication number: 20160280763
    Abstract: The present invention relates to albumin variants with an improved affinity for the neonatal Fc receptor (FcRn) and uses thereof, and in particular to the use of such albumin variants as carriers for immunogens. In some embodiments, the present invention relates to vaccines (e.g., vaccines for mucosal delivery) comprising albumin/immunogen fusion proteins.
    Type: Application
    Filed: October 31, 2014
    Publication date: September 29, 2016
    Inventors: Jan Terje Andersen, Inger Sandlie, Malin Bern